Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth

Journal of the American Society of Nephrology

Volumn 17, Issue 7, 2006, Pages 1886-1895

  Liang, Xiu Bin ^a   Ma, Li Jun ^a   Naito, Takashi ^a   Wang, Yihan ^a   Madaio, Michael ^c   Zent, Roy ^b,c   Pozzi, Ambra ^a,b   Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PUROMYCIN AMINONUCLEOSIDE; VASCULOTROPIN A; WORTMANNIN;

ANIMAL CELL; ARTICLE; BLOOD PRESSURE; CAPILLARY; CELL CULTURE; CELL DAMAGE; CELL GROWTH; CHRONIC KIDNEY DISEASE; CULTURE MEDIUM; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLOMERULAR ENDOTHELIAL CELL; GLOMERULOSCLEROSIS; GLOMERULUS EPITHELIUM; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; SUPERNATANT;

EID: 33745821648     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005020205     Document Type: Article

References (56)

1. Fogo AB: Progression and potential regression of glomerulosclerosis (Nephrology Forum). Kidney Int 59: 804-819, 2001
2. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69-75, 1998
3. Ma L-J, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB: Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 16: 966-976, 2005
4. Ma L-J, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB: Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 58: 2425-2436, 2000
5. Remuzzi A, Gagliardini E, Donadoni C, Fassi A, Sangalli F, Lepre MS, Remuzzi G, Benigni A: Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney Int 62: 885-894, 2002
6. Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E: Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 14: 2833-2842, 2003
7. Pesce CM, Striker LJ, Peten E, Elliot SJ, Striker GE: Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65: 601-605, 1991
8. Kitamoto Y, Tokunaga H, Tomita K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest 99: 2351-2357, 1997
9. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM: Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83: 233-240, 1998
10. Takahashi T, Huynh-Do U, Daniel TO: Renal microvascular assembly and repair: Power and promise of molecular definition. Kidney Int 53: 826-835, 1998
11. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W: Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8: 529-532, 1998
12. Risau W: Development and differentiation of endothelium. Kidney Int Suppl 67: S3-S6, 1998
13. Woolf AS, Yuan HT: Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development. Pediatr Nephrol 16: 177-184, 2001
14. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water L, Senger DR, Dvorak HF, Rosen S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42: 1457-1461, 1992
15. Satchell SC, Harper SJ, Tooke JE, Kerjaschki D, Saleem MA, Mathieson PW: Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 13: 544-550, 2002
16. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF: Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 7: 661-666, 1996
17. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ: Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37: 601-611, 2001
18. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434-1447, 2001
19. Petermann AT, Hiromura K, Blonski M, Pippin J, Monkawa T, Durvasula R, Couser WG, Shankland SJ: Mechanical stress reduces podocyte proliferation in vitro. Kidney Int 61: 40-50, 2002
20. Fishman JA, Karnovsky MJ: Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro. Am J Pathol 118: 398-407, 1985
21. Tiede K, Stoter K, Petrik C, Chen WB, Ungefroren H, Kruse ML, Stoll M, Unger T, Fischer JW: Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro. Cardiovasc Res 60: 538-546, 2003
22. Kanjanabuch T, Ma LJ, Guan YF, Mundel P, Fogo AB: Protective effects of peroxisome proliferator-activated receptor-gamma (PPARgamma) against puromycin aminonucleoside (PAN)-induced podocyte injury and death [Abstract]. J Am Soc Nephrol 14: 93A, 2003
23. Akis N, Madaio MP: Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int 65: 2223-2227, 2004
24. Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA: Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A 97: 2202-2207, 2000
25. Chen D, Roberts R, Pohl M, Nigam S, Kreidberg J, Wang Z, Heino J, Ivaska J, Coffa S, Harris RC, Pozzi A, Zent R: Differential expression of collagen- and laminin-binding integrins mediates ureteric bud and inner medullary collecting duct cell tubulogenesis. Am J Physiol Renal Physiol 287: F602-F611, 2004
26. Chen Y, da Rocha MJ, Morris M: Osmotic regulation of angiotensin AT1 receptor subtypes in mouse brain. Brain Res 965: 35-44, 2003
27. Flesch M, Hoper A, Dell'Italia L, Evans K, Bond R, Peshock R, Diwan A, Brinsa TA, Wei CC, Sivasubramanian N, Spinale FG, Mann DL: Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 108: 598-604, 2003
28. Garcia-Villalba P, Denkers ND, Wittwer CT, Hoff C, Nelson RD, Mauch TJ: Real-time PCR quantification of AT1 and AT2 angiotensin receptor mRNA expression in the developing rat kidney. Nephron Exp Nephrol 94: e154-e159, 2003
29. Shih SC, Robinson GS, Perruzzi CA, Calvo A, Desai K, Green JE, Ali IU, Smith LE, Senger DR: Molecular profiling of angiogenesis markers. Am J Pathol 161: 35-41, 2002
30. Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G: Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 63: 3403-3412, 2003
31. Munoz-Chapuli R, Quesada AR, Angel Medina M: Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61: 2224-2243, 2004
32. DeBusk LM, Hallahan DE, Lin PC: Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp Cell Res 298: 167-177, 2004
33. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273: 30336-30343, 1998
34. Dayanir V, Meyer RD, Lashkari K, Rahimi N: Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem 276: 17686-17692, 2001
35. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Dormer DB: Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275: 5096-5103, 2000
36. Stein RC: Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocr Relut Cancer 8: 237-248, 2001
37. Richer C, Bruneval P, Menard J, Giudicelli JF: Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats. Hypertension 31: 692-698, 1998
38. Fogo AB: The potential for regression of renal scarring. Curr Opin Nephrol Hypertens 12: 223-225, 2003
39. Zoja C, Corna D, Camozzi D, Cattaneo D, Rottoli D, Batani C, Zanchi C, Abbate M, Remuzzi G: How to fully protect the kidney in a severe model of progressive nephropathy: A multidrug approach. J Am Soc Nephrol 13: 2898-2908, 2002
40. Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordan KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ: Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 58: 2390-2399, 2000
41. Grone HJ, Simon M, Grone EF: Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 177: 259-267, 1995
42. Kang DH, Johnson RJ: Vascular endothelial growth factor: A new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 12: 43-49, 2003
43. Kliche S, Waltenberger J: VEGF receptor signaling and endothelial function. IUBMB Life 52: 61-66, 2001
44. Satchell SC, Mathieson PW: Angiopoietins: Microvascular modulators with potential roles in glomerular pathophysiology. J Nephrol 16: 168-178, 2003
45. Anderson S, Diamond J, Karnovsky M, Brenner B: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82: 1757-1768, 1988
46. Kurdi M, De Mello WC, Booz GW: Working outside the system: An update on the unconventional behavior of the renin-angiotensin system components. Int J Biochem Cell Biol 37: 1357-1367, 2005
47. McMullen M, Keller R, Sussman M, Pumiglia K: Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2. Oncogene 23: 1275-1282, 2004
48. Meadows KN, Bryant P, Pumiglia K: Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem 276: 49289-49298, 2001
49. Fujikawa K, de Aos Scherpenseel I, Jain SK, Presman E, Christensen RA, Varticovski L: Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp Cell Res 253: 663-672, 1999
50. Pedram A, Razandi M, Levin ER: Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 273: 26722-26728, 1998
51. Wheeler-Jones C, Abu-Ghazaleh R, Cospedal R, Houliston RA, Martin J, Zachary I: Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett 420: 28-32, 1997
52. Risau W: Mechanisms of angiogenesis. Nature 386: 671-674, 1997
53. Rousseau S, Houle F, Kotanides H, Witte L, Waltenberger J, Landry J, Huot J: Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J Biol Chem 275: 10661-10672, 2000
54. Rousseau S, Houle F, Landry J, Huot J: p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15: 2169-2177, 1997
55. Gerber HP, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and Al in vascular endothelial cells. J Biol Chem 273: 13313-13316, 1998
56. Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, Ahn BC, Koh GY: Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 86: 952-959, 2000